Dynavox Group Ab

Right. It's nine o'clock. Good morning and welcome to this earnings call. We will cover the first quarter in 2026, summarizing our business in January, February and March. I'm Fredrik Ruben. I am the CEO of Dynavox Group.

And I'm Linda Tybing. I'm the CEO of Dynavox Group and we'll cover the financials.

All right. And before, for some of those of you who have participated in this course before, you might be familiar, but we'll start with a quick recap about what China Docs Group does. And then we will summarize the main takeaways from the quarter. We will then dive deeper into the financials. And thereafter, there will be a Q&A session. And you can submit your questions during the Q&A session in the function here in Teams. Or you can ask them live by raising your hand in Teams. And, of course, unmute yourself when we will invite you to speak. And, of course, you're always welcome to offline questions sent by e-mail to the above e-mail, which is lindas, lindas.tidling at dynaboxgroup.com. So a brief overview of Dynabox Group. First and foremost, it's important to reiterate our mission and our vision, which I know is very dear not only to our now over 1,000 colleagues around the world, but also to our ecosystems of partners and investors. And our vision is a world where everyone can communicate. And we will contribute to this by focusing on our mission, which reads to empower people with disabilities to do what they once did or never thought possible. And this also summarizes two of our main user stories. The first one, the do what you once did, that may refer to a person who led a normal life until a diagnosis such as ALS, which rendered her then unable to control the body or communicate like before. The other one, the never thought possible, can refer to a child with a condition such as autism or cerebral palsy, where, thanks to our solution, she can do much more than the world around him or her ever thought possible. On the picture here you have Linnea. She's a 12-year-old girl from Gothenburg, here in Sweden, and she was diagnosed with cerebral palsy at an early age. And she's a great example of this. And Linnea presented at the Women in Tech conference here in Stockholm earlier this week, together with our colleague Grit, that you see in the picture. And thanks to our solution, she was able to fulfill one of her dreams, to give a lecture about assistive communication in front of thousands of people. And Linnea has been a user since she was about two years old. The market that we service is hugely underserved. Some 50 million people have a condition so grave, they simply cannot communicate unless they have a solution like ours. And every year, some 2 million people are being diagnosed, and yet we estimate that only 2% of those are actually being helped, and the rest literally remain silent. And the main reason for this spells lack of awareness, also among the professionals and the prescribers that are tasked to assist these users, and combined with poor healthcare reimbursement systems. We operate this company on a global footprint. Today, almost three-quarters of our business stems out of the U.S., largely because of a reasonably well-functioning funding system that was established some 20, 30 years ago. And our comprehensive solutions are sold in more than 65 markets around the world, which 12 are markets where we sell directly, while the others are serviced by a network of some 100 reseller partners. Our staff is distributed in a similar way as a revenue, meaning some 50% of our staff are based in North America, with our U.S. headquarters in Pittsburgh in Pennsylvania. And then our second largest office is our headquarters here in Stockholm. But we also have branch offices in several European countries, as well as in Suzhou in China, in Adelaide in Australia. And as of today, as I mentioned, we're just over 1,000 employees in total in the group. We provide a comprehensive portfolio of solutions that ranges from the content and the language system, such as the world's leading library of communication symbols, they're called PCS, and a leading solution of off-the-shelf custom-made synthetic voices of the highest quality and the large diversity, of course, of languages, ages, ethnicities, and so forth. We also make highly sophisticated communication software that's tailored to the type of user, And that can, of course, vary greatly based on the needs. Three, we develop and design devices with cutting-edge technology. And they're typically medically certified and very durable. And that includes communication aids that are controlled via eye tracking and accessories such as the re-adapt mounting systems. If we move on, we have a services portfolio to help our users. through the complexity of obtaining and getting funding or reimbursement for their solutions. And then last but not least, we're there to help our users, the therapists, the caregivers, through a global system of support resources. And we operate this model globally, and it's important to note that each piece on this picture is critically important and also a significant differentiator for us, making us absolutely unique. Our go-to-market model is predominantly as prescribed aid. So that means some 90% of our revenue comes from public or private insurance providers. And that also means that we have solid paying customers and have always been resilient towards changes in the overall economic climate. But now we will go back and focus on the main topic of today, namely our earnings report for the first quarter in 2026. If I just look at the highlights, we delivered a solid start to the year with continued revenue growth in the quarter. The growth compared to the same quarter previous year sums up to 15% after adjusting for currency effects. North America, our largest market, was hit, however, by unusually severe winter weather in January and in February. And that led to closures among schools and institutions. And this, of course, impacted our ability to meet with customers and deliver products. These effects are, however, expected to normalize and the deferred business to be regained during the remainder of this year. The month of March isolated, for example, was back at historic growth levels in North America. Our business in markets outside of North America continued on the good trajectory from the previous quarters. The demand, the underlying demand for our solutions remains high, and that's proving the solidity of our underlying business, and we see robust underlying growth across basically all markets where we operate. EBIT came in at 57 million SEC, and that's a 35% increase compared to the same quarter last year, despite continued FX headwinds and, of course, the named weather impact in the U.S., Our product and solutions development hub, which was formed last year here in Stockholm, is now fully operational. And then the global rollout of our new ERP system is now almost concluded. And now with also our Swedish parent company successfully transitioned earlier this month here in April, leaving only a few small local entities remaining. On 1st of April, we also completed the acquisition of our Italian reselling partner, SR Labs Healthcare. And we welcome new colleagues to the team. That's very exciting. And then last but not least, we announced a couple of changes to the executive management team. On March 1, we welcome Marie-José Leblond, or MJ as we refer to her, as the new chief digitalization and information officer. And also we welcome Luis Mustafa, who joined as our new chief operating officer. He's replacing Tony Pavlik, who's about to enter retirement. We also announced that Linda here will leave her position as our CFO, but will remain in full capacity until the end of January next year, 2027, hopefully voting for a smooth and structured transition after we have recruited her replacement. And now I actually do hand over to Linda, who indeed is still here and on top of things to take us deeper into the financials. Linda.